Details of the Drug
General Information of Drug (ID: DMADZQ9)
| Drug Name |
4-(trifluoromethyl)phenylboronic acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
128796-39-4; 4-(Trifluoromethyl)phenylboronic acid; 4-trifluoromethylphenylboronic acid; 4-(Trifluoromethyl)benzeneboronic acid; (4-(trifluoromethyl)phenyl)boronic acid; [4-(Trifluoromethyl)phenyl]boronic acid; (4-Trifluoromethylphenyl)boronic acid; [4-(trifluoromethyl)phenyl]boranediol; 4-Boronobenzotrifluoride; p-(trifluoromethyl)phenylboronic acid; CHEMBL143654; alpha,alpha,alpha-Trifluoro-p-tolylboronic acid; 4-trifluoromethylphenyl boronic acid; 4-trifluoromethylphenyl-boronic acid; MFCD00151855; Boronic acid, [4-(tr
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 |
Molecular Weight | 189.93 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
| Rotatable Bond Count | 1 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count | 5 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


